Physician profile
Gregg Willis
NPI 1336171511
$2,937.26
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,565 · 2020: $89.90 · 2021: $282.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,500.00 | 2019 | |
| Pfizer INC. | $128.50 | 2019-2021 | |
| Aspira Women'S Health INC | $63.69 | 2021 | |
| Abbvie INC. | $51.93 | 2021 | |
| Roche Diagnostics Corporation | $42.73 | 2021 | |
| Myovant Sciences INC. | $39.73 | 2021 | |
| Therapeuticsmd, INC. | $29.98 | 2019 | |
| Avion Pharmaceuticals | $23.56 | 2019 | |
| Mylan Pharmaceuticals INC. | $21.00 | 2021 | |
| Daiichi Sankyo INC. | $18.17 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.97 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregg Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.